Research institute
Screening using EMR data could help with early identification of Alzheimer’s disease risk
The Life Science Women’s Conference is being held on February 19 and 20 at the Tampa Bay Convention Center in Tampa, Florida. Co-founded by Patti Rossman and Steve Fiske, the conference is an opportunity for women to accelerate their life science careers via mentoring, networking and education.
The microbiome is the trillions of microorganisms that live in and on the body. Although it makes complete sense that these would play a factor in gastrointestinal diseases, such as Crohn’s and colitis, it’s less obvious that it would play a role in anything ranging from lung diseases to neurodegenerative diseases.
As public health leaders from around the world, including the U.S. Centers for Disease Control and Prevention, work to contain the spread of the 2019 Novel Coronavirus, a team at Regenstrief Institute, an international leader in health information technology, is providing help to track cases of the illness.
Renowned drug discovery leader to guide alliance formed to improve scientific exchange in UK drug discovery community
A clearer picture of how DNA changes lead to cancer has emerged, following the most comprehensive evaluation of non-coding driver mutations to date by researchers at the Wellcome Sanger Institute, the Broad Institute of MIT and Harvard, Massachusetts General Hospital, Aarhus University Hospital and their collaborators.
There’s a growing demand for life sciences professionals in Massachusetts, but a new report indicates that the home-grown talent pipeline is not adequate enough to meet the growing demands in the Bay State.
Every week there are numerous scientific studies published. Here’s a look at some of the more interesting ones.
The most recent figure for the China coronavirus outbreak is 28,018 confirmed cases with 563 deaths in China. Chinese health authorities indicate 19 foreigners have been infected by the virus. There are reports that a Chinese newborn is the youngest person to become infected. The infant was diagnosed 30 hours after birth, apparently having gotten it from the mother.
Jeffrey Bluestone, the noted scientific researcher and pioneer in understanding T-cell activation and immune tolerance in cancer patients, has stepped down from his role as chief executive of the Parker Institute for Cancer Immunotherapy to launch Sonoma Biotherapeutics.
PRESS RELEASES